These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9608836)

  • 1. [Restenosis after percutaneous coronary angioplasty--cause, prevention strategies].
    Szyguła J; Puzio B; Poloński L
    Wiad Lek; 1998; 51(1-2):76-81. PubMed ID: 9608836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pathophysiology of restenosis following percutaneous transluminal coronary angioplasty].
    Holm AM; Haunsø S; Hansen PR
    Ugeskr Laeger; 1998 Feb; 160(9):1302-6. PubMed ID: 9495077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The paradigm of restenosis following percutaneous transluminal coronary angioplasty.
    Preisack MB; Karsch KR
    Eur Heart J; 1993 Nov; 14 Suppl I():187-92. PubMed ID: 8293774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Restenosis after percutaneous transluminal coronary angioplasty and its prevention].
    Przewłocka-Kosmala M; Kosmala W
    Przegl Lek; 1999; 56(10):671-5. PubMed ID: 10695384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Restenosis: physiopathology, treatments and prevention].
    Lafont A; Durand E; Rahal S; de Oliveira M; Guérin Y; Fernandez F; Desnos M; Guérot C
    Ann Cardiol Angeiol (Paris); 1995 Sep; 44(7):349-53. PubMed ID: 8561439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors influencing restenosis after coronary angioplasty.
    Popma JJ; Topol EJ
    Am J Med; 1990 Jan; 88(1N):16N-24N. PubMed ID: 2195881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mechanisms and prevention of restenosis after coronary angioplasty].
    Drechsel S; Bertel O; Lafont A
    Schweiz Med Wochenschr; 1998 Mar; 128(13):497-507. PubMed ID: 9583101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preprocedural level of soluble CD40L is predictive of enhanced inflammatory response and restenosis after coronary angioplasty.
    Cipollone F; Ferri C; Desideri G; Paloscia L; Materazzo G; Mascellanti M; Fazia M; Iezzi A; Cuccurullo C; Pini B; Bucci M; Santucci A; Cuccurullo F; Mezzetti A
    Circulation; 2003 Dec; 108(22):2776-82. PubMed ID: 14623801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimally invasive angioplasty: acute and long term results of low pressure dilatation with a non-compliant balloon during percutaneous transluminal coronary angioplasty.
    Shawl FA
    J Invasive Cardiol; 1993 Apr; 5(3):122-7. PubMed ID: 10146583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Results of coronary heart disease treatment with coronary angioplasty in patient over 65].
    Chizyński K
    Przegl Lek; 2003; 60(7):456-60. PubMed ID: 14750418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Restenosis after coronary angioplasty. Contribution of experimental models].
    Bauters C; Hamon M; Van Belle E; Dupuis B; Lablanche JM; Bertrand ME
    Arch Mal Coeur Vaiss; 1993 Jan; 86 Spec No 1():47-56. PubMed ID: 8215780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized comparison of J&J Crown stent versus NIR stent after routine coronary angioplasty.
    Miketic S; Carlsson J; Tebbe U
    Am Heart J; 2001 Nov; 142(5):E8. PubMed ID: 11685183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restenosis after percutaneous transluminal coronary angioplasty in patients with non-insulin-dependent diabetes mellitus (NIDDM).
    Asakura Y; Suzuki M; Nonogi H; Haze K; Sato A; Inada H; Okuda Y; Yamashita K; Harano Y
    J Cardiovasc Risk; 1998; 5(5-6):331-4. PubMed ID: 9920005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prediction of restenosis after percutaneous transluminal coronary angioplasty using coronary flow reserve. Kansai Doppler Guide Wire Study Group].
    Toda I; Teragaki M; Nishida Y; Kobayashi Y; Shimada K; Yoshiyama M; Akioka K; Takeuchi K; Yoshikawa J
    J Cardiol; 2000 Mar; 35(3):165-73. PubMed ID: 10808423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous interventional strategies in the treatment of chronic total coronary occlusions.
    Lau KW; Ding ZP; Sigwart U; Lam L
    Singapore Med J; 2000 Sep; 41(9):468-70. PubMed ID: 11193123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Percutaneous transluminal coronary angioplasty for restenosis following Palmaz-Schatz stenting: larger size balloons are more effective?].
    Kishi K; Hiasa Y; Suzuki N; Miyamoto H; Takahashi T; Hosokawa S; Tanimoto M; Otani R
    J Cardiol; 1999 Aug; 34(2):55-60. PubMed ID: 10466086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Personality and restenosis after percutaneous transluminal coronary angioplasty].
    Betkowska-Korpała B; Jankowski P; Bryniarski L; Królikowski T; Dudek D; Zmudka K; Kawecka-Jaszcz K
    Przegl Lek; 2000; 57(5):274-7. PubMed ID: 11057116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New strategies in the treatment of restenosis].
    von Hodenberg E; Tost B; Scheffold T
    Z Kardiol; 2000; 89 Suppl 7():19-22. PubMed ID: 11098555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in the pig coronary artery injury model: comparison of plain old balloon angioplasty and stent implantation].
    Shimizu N; Suzuki H; Wakabayashi K; Iso Y; Shibata M; Yorozuya M; Katagiri T; Takeyama Y
    J Cardiol; 2004 Mar; 43(3):131-9. PubMed ID: 15067801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The angiotensinogen gene 235T variant is associated with an increased risk of restenosis after percutaneous transluminal coronary angioplasty.
    Völzke H; Hertwig S; Rettig R; Motz W
    Clin Sci (Lond); 2000 Jul; 99(1):19-25. PubMed ID: 10887054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.